Hologic Inc (NASDAQ:HOLX)

During the Trading Day
24.34 -0.45 / -1.82%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
24.34 0.00 / 0.00%
 
Volume: 73.4K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$6.9B

Company Description

Hologic, Inc. develops, manufactures and supplies diagnostics products, medical imaging systems and surgical products dedicated to serve the healthcare needs of women. The company operates through four business segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Breast Health segment products include a broad portfolio of breast imaging and related products and accessories, including digital and film-based mammography systems, magnetic resonance imaging, breast coils, computer-aided detection for mammography and MRI, minimally invasive breast biopsy devices, breast biopsy site markers, breast biopsy guidance systems, breast imaging comfort pads, and breast brachytherapy products. It has also developed a new breast imaging platform, Dimensions, which utilizes a new technology, tomosynthesis, to produce three dimensional images, as well as conventional two dimensional full field digital mammography images. The Diagnostics segment products include the ThinPrep system, which is primarily used in cytology applications such as cervical cancer screening, the Rapid Fetal Fibronectin Test, which assists physicians in assessing the risk of pre-term birth, and its molecular diagnostic reagents used for a variety of DNA and RNA analysis applications based on its proprietary Invader chemistry. Its current molecular diagnostic offerings based upon this Invader chemistry include Cervista HPV high risk and Cervista HPV 16/18 products to assist in the diagnosis of human papillomavirus, as well as other products to diagnose cystic fibrosis, cardiovascular risk and other diseases. The GYN Surgical segment products include the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Adiana Permanent Contraception System. The NovaSure system is a minimally invasive procedure for the treatment of heavy menstrual bleeding. The MyoSure system is a tissue removal device that is designed to provide incision-less removal of fibroids and polyps within the uterus. The Adiana system is a form of permanent female contraception intended as an alternative to tubal ligation. The Skeletal Health segment products include dual-energy X-ray bone densitometry systems, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in October 1985 and is headquartered in Bedford, MA.

Contact Information

Hologic, Inc.
35 Crosby Drive
Bedford Massachusetts 01730-1450
P:(781) 999-7300
Investor Relations:
(781) 999-7716

Employees

Shareholders

Mutual fund holders56.37%
Other institutional43.80%
Individual stakeholders2.22%

Top Executives

Stephen P. MacMillanPresident, Chief Executive Officer & Director
Eric B. ComptonChief Operating Officer
Robert W. McMahonChief Financial Officer
Jay A. SteinChairman-Emeritus, Chief Technology Officer & SVP
Glenn P. MuirExecutive Vice President-Administration

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.